Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
The inspection was concluded with zero observations
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
Revolutionary technology will further boost OneSource’s scientific services offerings
More emphasis should be given on investing healthcare resources towards prevention of diseases rather than only focusing on diagnostic and therapeutic options
The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency and severity of moderate to severe vasomotor symptoms over 12 weeks compared to placebo
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Report highlights significant improvements in adolescent well-being in India
Subscribe To Our Newsletter & Stay Updated
